| PACKAGING TYPE: | 10x10 Alu-alu ( 10 Strip In 1 Box ) |
| COMPOSITION: | Gliclazide (80mg) + Metformin (500mg) |
| FORMULATION: | Tablet |
| Description: | GLYZIMAC M Tablet is a combination antidiabetic medication containing: Gliclazide 80mg – a sulfonylurea that stimulates insulin secretion from pancreatic beta cells. Metformin 500mg – a biguanide that reduces hepatic glucose production and improves insulin sensitivity. This combination is used in the management of Type 2 Diabetes Mellitus, especially in patients who require dual therapy for better glycemic control. GLYZIMAC M helps regulate both fasting and postprandial blood glucose levels, reducing the risk of diabetes-related complications. |
| Side Effects: | Common side effects: Nausea or diarrhea Abdominal discomfort Headache Hypoglycemia (low blood sugar) Rare but serious side effects: Lactic acidosis (rare, due to Metformin) Severe hypoglycemia Liver or kidney function abnormalities Allergic reactions (rash, swelling, difficulty breathing) |
| How to Use: | Take GLYZIMAC M Tablet orally, usually once or twice daily with meals or as prescribed. Swallow the tablet whole with water. Do not skip meals to prevent hypoglycemia. Maintain a healthy diet and regular exercise routine. Monitor blood glucose levels regularly. |
| Precaution: | Monitor for symptoms of hypoglycemia (sweating, dizziness, confusion). Use cautiously in patients with kidney or liver impairment. Avoid excessive alcohol consumption (risk of lactic acidosis). Inform your doctor about other medications to avoid interactions. Not recommended during pregnancy or breastfeeding without medical advice. |
| Product Benefits: | Provides dual-action blood sugar control. Helps reduce fasting and post-meal glucose levels. Improves insulin secretion and sensitivity. Reduces risk of long-term diabetic complications. Effective for patients not controlled on single-drug therapy. |
Frequently Asked Questions
It is used to manage Type 2 Diabetes Mellitus by controlling blood sugar levels.
The combination provides better blood sugar control by improving insulin secretion and reducing glucose production.
Yes, due to Gliclazide, it may cause hypoglycemia, especially if meals are skipped.











